StockData
Axogen, Inc. logo

Axogen, Inc. (AXGN) stock

AXGNNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/30142% above fair value
$55.37−0.01 (-0.02%)

Close on Nov 17, 2026Market cap $3.31BP/E –Yield –

Axogen cash

Cash and short-term investments held at the end of each period.

Axogen's cash was $348.07M at Sep 30, 2026. For fiscal 2025 it was $41.53M, up 5.2% from the year before. Over ten years it grew 4.8% a year on average. The highest annual figure on record is $122.61M in fiscal 2018.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$41.53M+5.2%
FY2024Dec 31, 2024$39.48M+6.6%
FY2023Dec 31, 2023$37.03M-32.7%
FY2022Dec 31, 2022$55.04M-39.1%
FY2021Dec 31, 2021$90.34M-18.5%
FY2020Dec 31, 2020$110.81M+8.1%
FY2019Dec 31, 2019$102.51M-16.4%
FY2018Dec 31, 2018$122.61M+235.8%
FY2017Dec 31, 2017$36.51M+21.6%
FY2016Dec 31, 2016$30.02M+15.8%
FY2015Dec 31, 2015$25.91M+215.4%
FY2014Dec 31, 2014$8.22M-59.1%
FY2013Dec 31, 2013$20.07M+44.3%
FY2012Dec 31, 2012$13.91M+69.8%
FY2011Dec 31, 2011$8.19M+355.3%
FY2010Dec 31, 2010$1.80M+536.2%
FY2009Dec 31, 2009$282.80K–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$348.07M+774.7%
Q2 FY2026Jun 30, 2026$111.41M+210.1%
Q1 FY2026Mar 31, 2026$101.60M+262.0%
Q4 FY2025Dec 31, 2025$41.53M+5.2%
Q3 FY2025Sep 30, 2025$39.79M+30.3%
Q2 FY2025Jun 30, 2025$35.92M+32.4%
Q1 FY2025Mar 31, 2025$28.07M+18.8%
Q4 FY2024Dec 31, 2024$39.48M+6.6%
Q3 FY2024Sep 30, 2024$30.53M-20.9%
Q2 FY2024Jun 30, 2024$27.13M-33.5%
Q1 FY2024Mar 31, 2024$23.63M-46.4%
Q4 FY2023Dec 31, 2023$37.03M-32.7%
Q3 FY2023Sep 30, 2023$38.59M-35.0%
Q2 FY2023Jun 30, 2023$40.78M-36.6%
Q1 FY2023Mar 31, 2023$44.12M-40.1%
Q4 FY2022Dec 31, 2022$55.04M-39.1%
Q3 FY2022Sep 30, 2022$59.36M-39.5%
Q2 FY2022Jun 30, 2022$64.28M-39.5%
Q1 FY2022Mar 31, 2022$73.67M-24.2%
Q4 FY2021Dec 31, 2021$90.34M-18.5%
Q3 FY2021Sep 30, 2021$98.05M-8.1%
Q2 FY2021Jun 30, 2021$106.25M-3.4%
Q1 FY2021Mar 31, 2021$97.24M+9.2%
Q4 FY2020Dec 31, 2020$110.81M+8.1%
Q3 FY2020Sep 30, 2020$106.74M+0.6%
Q2 FY2020Jun 30, 2020$109.94M+0.8%
Q1 FY2020Mar 31, 2020$89.04M-21.8%
Q4 FY2019Dec 31, 2019$102.51M-16.4%
Q3 FY2019Sep 30, 2019$106.07M-16.1%
Q2 FY2019Jun 30, 2019$109.06M-18.3%
Q1 FY2019Mar 31, 2019$113.85M+272.5%
Q4 FY2018Dec 31, 2018$122.61M+235.8%
Q3 FY2018Sep 30, 2018$126.37M+473.3%
Q2 FY2018Jun 30, 2018$133.56M+459.5%
Q1 FY2018Mar 31, 2018$30.56M+17.9%
Q4 FY2017Dec 31, 2017$36.51M+21.6%
Q3 FY2017Sep 30, 2017$22.04M–
Q2 FY2017Jun 30, 2017$23.87M–
Q1 FY2017Mar 31, 2017$25.91M–
Q4 FY2016Dec 31, 2016$30.02M–

More Axogen figures

See a number that looks wrong?